Changes in extranucleolar transcription during acitnomycin D-induced apoptosis by Fraschin, Annunzia et al.
Summary. Actinomycin D (AMD) inhibits DNA-
dependent RNA polymerases and its selectivity depends
on the concentration used; at very high concentrations it
may also induce apoptosis. This study investigates the
effects of different concentrations (0.01 to 1 µg/ml) of
AMD on RNA transcription and maturation and on the
organization of nuclear ribonucleoproteins (RNPs), and
their relationship with apoptosis induction. Human HeLa
cells were used as a model system. At the lowest
concentration used, AMD induced the segregation of the
nucleolar components and impaired r-RNA synthesis, as
revealed by the decreased immunopositivity for bromo-
uridine incorporation and for DNA/RNA hybrid
molecules. The synthesis of pre-mRNAs, on the
contrary, was active, while the immunolabeling of
snRNP proteins and of the SC-35 splicing factor strongly
decreased on perichromatin fibrils (where they are
involved in co-transcriptional splicing). This suggests
that the post-transcriptional maturation of extranucleolar
RNAs was also affected. Moreover, still in the absence
of typical late morphological or biochemical signs of
apoptosis (i.e. chromatin condensation), these cells
displayed the early apoptotic features, i.e. the
externalization of phosphatidylserine residues on the
plasma membrane and propidium iodide exclusion in
vivo. At the highest concentrations of AMD used,
apoptosis massively occurred, with the typical
morphological events (progressive chromatin
condensation, clustering of snRNPs and SC-35 splicing
factor, cell blebbing). However, transcription of hnRNAs
was maintained in the residual areas of diffuse chromatin
up to advanced apoptotic stages. The inhibition of rRNA
synthesis and the defective pre-mRNA maturation seem
to be part of the apoptotic process induced by AMD.
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Introduction
Actinomycin D (AMD) is an antibiotic which is able
to bind DNA duplexes and to inhibit DNA-dependent
RNA polymerases (Chen, 1988; Puvion-Dutilleul et al.,
1992). At low concentrations (0.04-0.05 µg/ml), AMD
specifically inhibits r-RNA synthesis in cultured cells,
consistent with its selectivity for GC bases; at high
concentration, however, AMD also affects the synthesis
of other RNAs (Perry and Kelley, 1968; Peter et al.,
1999). Under these conditions, apoptosis can also be
induced in several cell lines (i.e. HL-60 human leukemic
cells: Martin et al., 1990; Naora et al., 1996). In fact,
defective, altered or arrested transcription may potentiate
apoptosis even in normal and tumor cell lines, which are
usually resistant to cell death induced by several agents
(i.e. DNA-damaging agents: Martin, 1993; Andera and
Wasylyk, 1997; Peter et al., 1999). 
The aim of the present study was to investigate the
behaviour of the extranucleolar RNA (hnRNA or pre-
mRNA) synthesis and of its maturation process in AMD-
induced apoptosis.
In the nucleus, RNA transcription and transcripts’
maturation occur in specific structures which have been
described, at electron microscopy, as perichromatin
fibrils (PF), perichromatin granules (PG), and
interchromatin granules (IG) (Fakan, 1994, 2004;
Spector, 1996). In particular, PF are the morphological
equivalent of hnRNA transcription and co-
transcriptional splicing, while IG represent a storage site
for snRNP and non-snRNP splicing factors and are a
possible site for spliceosome assembly (Misteli and
Spector, 1998; Melcak et al., 2001). Finally, PG are
involved in the storage and the nucleus-to-cytoplasm
transport of mRNA (Fakan, 1994, 2004). All these
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components have specific intranuclear location (PF and
PG, at the periphery of condensed chromatin; IG, in the
so-called interchromatin space), which is an essential
pre-requisite for the correct maturation of nuclear RNAs
(for reviews, see Puvion and Puvion-Dutilleul, 1996;
Fakan, 2004).
In the present investigation, different concentrations
of AMD were used in the attempt to monitor the changes
in nucleolar and extranucleolar RNA synthesis and
processing in relation to the occurrence of apoptosis.
HeLa cells have been selected as a model cell system,
and immunocytochemical techniques, at light and
electron microscopy, have been mainly used to label the
sites of pre-mRNA synthesis, and to detect the
incorporation of RNA precursors and the presence of
DNA/RNA hybrid molecules. To follow the intranuclear
locations of the post-synthetic RNA processing, some
key proteins such as hnRNP, snRNP and the SC-35
splicing factor were immunolabeled. Cytometric and
electrophoretic techniques have been used to detect the
presence of apoptotic cells and to estimate their
percentages.
Materials and methods
Cells, culture conditions and treatments
HeLa cells were grown in D-MEM Medium,
containing 10% fetal bovine serum, 2 mM glutamine and
100 units each of streptomycin and penicillin (Celbio
S.r.l., Milano, Italy). The cells were grown at 37 °C in a
humified atmosphere containing 5% CO2, and were
grown either in 25 cm2 flasks or planted on glass
coverslips in Petri dishes.
2x104 cells/cm2 were seeded and allowed to grow in
culture for 48 hr; the cell cultures were then treated for
12 hr with AMD at different final concentrations (0.01,
0.1 or 1 µg/ml). The time of treatment was selected,
based on preliminary experiments in which AMD
exposure lasted for 30 min to 24 hr. Control cell samples
were grown in complete fresh medium without AMD. 
Cells were harvested by mild trypsinization (0.25%
trypsin containing 0.05% EDTA in PBS) and processed
for electron microscopy cytochemistry, fluorescence
microscopy, cytofluorometry or the biochemical assays
(see below). 
Detection of RNA synthesis
3H-Uridine Incorporation: Control and AMD-treated
cell samples were incubated for 1 hr with 7 µCi of 3H-
uridine (Amersham, UK: specific activity 26 Ci/mMol).
After removing the radioactive medium, cells were
washed with PBS, and lysed with 1 ml of 1M NaOH for
10 min at 37 °C. Cell lysates were then transferred to 10
ml tubes, and nucleic acids were precipitated with 3 ml
of cold 20% TCA. Radioactive material was recovered
by precipitation under vacuum on GF/C filters, which
were washed three times with cold 3% TCA, once with
cold ethanol, and dried. Radioactivity was measured by
liquid scintillation in a beta Counter Beckman LS 6000.
Experiments were performed in triplicate. 
Bromo-Uridine incorporation: Control and AMD-
treated cells were incubated for 30 min. with 25mM
bromo-uridine (BrU: Sigma Chemical Co., St. Louis,
CA, USA.), as originally suggested for non isotopic
precursors by Dundr and Raska (1993). Cells were then
fixed in suspension with 70% ethanol, washed in PBS
and incubated for 60 min at room temperature with a
mouse monoclonal anti-bromodeoxyuridine (BrdU)
antibody B44 (Becton-Dickinson, San José, CA, USA),
which has affinity also for BrU, thus recognizing BrU-
substituted RNA, without previous acid hydrolysis
(Jensen et al., 1993). The anti-BrdU antibody was
diluted 1:10 in PBS (containing 0.05% Tween 20 and
0.1% bovine serum albumin), then revealed with an
FITC-conjugated goat anti-mouse antibody (Sigma
Chemical Co). Cell samples were finally counterstained
for at least 30 min at room temperature with 5 µg/ml
propidium iodide (PI in 0.1 M phosphate buffer pH 7.2,
containing 100 units/ml RNAse A from Sigma).
Bivariate measurements of green fluorescence
(identifying immunolabeled cells) versus red
fluorescence (PI-DNA content) were made with a
Becton Dickinson (San José, CA, USA) FACStar flow
cytometer. This was carried out under the following
conditions: argon ion laser excitation power 200 mW at
488 nm, 560 nm beam splitter, 510-540 nm band pass
filter for the green fluorescence detector, and 610 nm
long pass filter for the red fluorescence detector. The
level of background fluorescence, due to the non-
specific binding of the FITC-conjugated antibodies, was
established using control cell specimens processed as
described above, but either without incubation with the
primary antibodies or with incubation with a mouse
serum containing no specific antigenic activity: the
corresponding value of green fluorescence was used as a
cut-off value above which cells were considered as
labeled. Dual parameter cytometric data were evaluated
with rectangular region analysis: FITC-immunolabeled
cells were those with green fluorescence values
exceeding the background threshold determinated as
reported above; the ranges for G0-G1, S and G2-M phase
cells were established on the basis of the corresponding
DNA content histograms. At least 20,000 cells per
sample were considered in the gated region used for
calculations.
Detection of BrU incorporation, DNA/RNA hybrid
molecules and RNPs at electron microscopy
For ultrastructural cytochemistry, the cells were
fixed in suspension with 2% p-formaldehyde containing
0.2% glutaraldehyde in D-MEM medium for 1 h at 4 °C.
The samples were then centrifuged and embedded in 2%
agarose. Small fragments were dehydrated in ethanol
and finally embedded in LRWhite resin. 60-70 nm thick
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sections were cut and mounted on nickel grids.
The characteristics of the monoclonal and polyclonal
antibodies used are listed in Table 1. After pre-
incubation with normal goat serum (1:100 dilution in
PBS, pH 7.4 for 3 min) the grids were incubated
overnight with one of the primary antibodies diluted in
PBS contaning 0.05% of Tween 20 and 0.1% of bovine
serum albumin, then revealed by gold-conjugated
secondary antibodies for 30 min; all incubations were
performed at 23 °C.
Since the presence of BrU incorporated into pre-
mRNA molecules can inhibit splicing (Wansink et al.,
1994), the antibodies specific for proteins involved in
splicing were used on cells cultured in the absence of
BrU. As a control of the specificity of the reactions,
some grids were processed in the absence of the primary
antibody.
BrU incorporation was detected using the anti-BrdU
B44 antibody (Becton-Dickinson), followed by the gold-
conjugated goat-anti-mouse antibody (Jackson Immuno
Research Laboratories, Pennsylvania, USA). As a
specificity control for the labelling, the immunoreaction
was also performed after digestion with RNase A (100
KU/ml at 37 °C for 2 hr).
DNA/RNA hybrid molecules were detected by a
goat polyclonal antibody (Testillano et al., 1994), and
revealed by a gold conjugated rabbit anti-goat antibody
(Multilab, Fetcham, England).
To label hnRNPs involved in hnRNAs processing, the
C8V chicken polyclonal antibody raised against hnRNP
core proteins (Jones et al., 1980; Martin and Okamura,
1981; Leser et al., 1984) was used; the grids were then
reacted with a rabbit anti-chicken antibody and finally
visualized by gold-conjugated goat-anti-rabbit IgG
(Multilab, Fetcham, England).
snRNPs labeling: Hybridoma supernatant containing
the monoclonal antibody recognizing the Sm complex
present on U1, U2, U2/U6 and U-5 snRNP (Lerner et al.,
1981) was used and then reacted with a goat-anti-human
IgG coupled with gold particles (Aurion, Wageningen,
The Netherlands).
The non-snRNP splicing factor SC-35 was
immunolabeled with the specific mouse monoclonal
antibody (Fu and Maniatis, 1992) (Sigma Chemical Co.),
then evidenced by gold-conjugated IgG+IgM (Multilab).
At the end of all the immunocytochemical
procedures, the sections were stained with Bernhard’s
regressive EDTA method (Bernhard, 1969), in order to
evidence the nuclear structures containing RNPs, such as
PG and IG.
The sections were examined and photographed
under a Zeiss TEM 900 at 80kV.
Fluorescence microscopy
Micrographs were obtained from cells grown on
glass coverslips and immunoreacted to detect either BrU
incorporation or SC-35 splicing factor, using FITC-
conjugated secondary antibodies, in the same conditions
as described above. Cells were then counterstained for
DNA with 0.1 µg/ml Hoechst 33258 (Sigma Chemical
Co.) in PBS for 15 min.
After the cytochemical procedures, slides were
mounted in Mowiol 4-88 (Calbiochem, La Jolla, CA,
USA) and observed with an Olympus BX 50 microscope
equipped with a 100W mercury lamp. The following
conditions were used: 330-385 nm excitation filter
(excf), 400 nm dichroic mirror (dm) and 420 nm barrier
filter (bf), for Hoechst; 450-480 nm excf, 500 nm dm
and 515nm bf for FITC. The images were recorded with
an Olympus Camedia C-2000 Z digital camera and
stored for processing on a PC by the Olympus software.
Identification of apoptotic cells
Labeling of phosphatidylserine residues on the outer
leaflet of the plasma membrane: Unfixed cells were
incubated with FITC-conjugated annexin V (3 µl/106
cells, Bender MedSystem, Prodotti Gianni, Milano,
Italy) and counterstained with 2 µg/ml PI. After 10 min
of incubation, dual-parameter flow cytometric analysis
was perfomed with a FACStar flow cytometer as
reported above.
Phosphatidylserine residues were also labeled for
electron microscopy, using biotin-conjugated Annexin V
(3 µl/106 cells, Bender MedSystem). Cells were then
fixed with 2% glutaraldehyde, dehydrated and embedded
in LR White resin. Ultra-thin sections were reacted with
a gold-conjugated goat anti-biotin antibody (Aurion,
Wageningen, The Netherlands) 1:5 in PBS for 30 min at
room temperature (Pellicciari et al., 1997). As a control
for the reaction specificity, some sections were pre-
treated with streptavidin to block biotin.
Detection of hnRNP proteins by Western blot
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Table 1. Antibodies.
ANTIBODY SOURCE ANTIGEN DILUTION SECONDARY MARKER REFERENCE
Anti-BrdU mouse, monoclonal Br-uridine 1:5 GAM IgG+IgM (12 nm) Jensen et al., 1993
Anti-hybrid goat, policlonal DNA/RNA hybrids 1:100 RAG, 20 nm Testillano et al., 1994
C8V chicken, polyclonal hnRNP core proteins 1:3000 Rabbit anti-chicken / GAR, 12 nm Martin and Okamura, 1981
Anti-Sm autoimmune serum Sm antigen (U1, U2, U4/6, U5 snRNP) 1:200 GAHu, 12 nm Lerner et al., 1981
SC-35 mouse, monoclonal SC-35 non snRNP splicing factor 1:100 GAM IgG+IgM, 12 nm Fu and Maniatis, 1992
analysis: Cells were washed twice with ice-cold PBS and
resuspended at the concentration of 5x106 cells/ml in
denaturing buffer containing 62.5 mM Tris-HCl (pH
6.8), 4 M urea, 10% glycerol, 2% beta-mercaptoethanol
and 0.003% bromophenol blue (Shah et al., 1995). Cells
were then disrupted by sonication on ice, twice for 30 s
at 60W. Equal volumes of each sample were incubated
for 15 min at 65 °C before loading on SDS-
polyacrylamide gel, electrophoresed in a 7.5% SDS-
PAGE minigel and transferred by standard procedures to
nitrocellulose filters (Biorad, Hercules, CA, USA). The
membranes were saturated overnight with PBS
containing 10% newborn calf serum and 0.2% Tween
(PTN) and then incubated overnight with the chicken
polyclonal antibody C8V against hnRNPs (Martin and
Okamura, 1981), 1: 10000 in PTN. After washing with
PBS containing 0.2% Tween 20, the membrane was
incubated for 2 hr with the appropriate secondary
antibody conjugated to horseradish peroxidase.
Visualization of peptides was achieved by ECL system
(NEN-Dupont, Boston, USA).
Results
Under control growth conditions, BrU incorporation
takes place all over the nucleus, including the nucleoli
which were strongly immunopositive (Fig. 1a). After 12
hr of treatment with 0.01 µg/ml of AMD (Fig. 1b), the
nucleoli were unlabelled, whereas the extranucleolar
nuclear areas were still immunopositive; it is worth
noting that similar results were already obtained after 30
min of treatment with 0.01 µg/ml of AMD (not shown).
After 12 hr of treatment with higher AMD
concentrations (0.1-1 µ g/ml: Fig. 1c,d), the
extranucleolar labeling also decreased. The quantitative
variations in BrU incorporation were apparent from the
flow cytometric analyses as well as the experiments of
3H-uridine incorporation (Fig. 2 and Table 2).
At the electron microscope, in control cells both the
incorporation of BrU (Fig. 3a) and the presence of
DNA/RNA hybrids (Fig. 4a) were found in the fibrillar
component of the nucleolus and in the PF; such RNP-
containing structures were preferentially stained with the
EDTA regressive procedure. In cells treated with 0.01
µg/ml AMD, nucleoli underwent segregation and only a
weak (or even absent ) immunogold labeling for BrU
(Fig. 3b) and for DNA/RNA hybrid molecules was
observed (Fig. 4b); consistent with the
immunofluorescent experiments, incorporation of BrU
still occurred outside the nucleolus, in the PF, where
DNA/RNA hybrid molecules were also detected; this
suggests that pre-mRNA synthesis was still active. The
hnRNP core proteins, which associate to newly
synthesized pre-mRNA, were present on PF in control
cells (Fig. 5a) and were still observed after AMD
treatment (Fig. 5b). 
In control cells, the protein components necessary
for splicing, such as snRNPs (Fig. 6a) and the SC-35
splicing factor (Fig. 7a), were localized on the PF (where
co-transcriptional splicing is also known to occur), and
on the IG (which serve as storage sites for splicing
proteins). At light microscopy, the immunopositivity for
SC-35 in untreated cells was present in the nucleus
either as fluorescent spots or as a diffuse pattern (Fig. 7a,
inset). 
After 0.01 µg/ml AMD, the immunolabeling of both
snRNP (Fig. 6b) and the SC-35 splicing factor (Fig. 7b),
at the electron microscope, strongly decreased on PF,
while a residual positivity was present on the IG which
appeared more clustered than in controls; consistently, at
light microcopy the diffuse immunopositivity was highly
reduced, whereas the fluorescent spots were still evident
and increased in size (Fig. 7b, inset).
No significant changes in chromatin organization
still occurred in cells treated for 12 hr with 0.01 µg/ml of
AMD (Fig. 6b), although about 20% of the cells started
to display phosphatidylserine residues at the surface of
the plasma membrane (Fig. 6b, inset and Fig. 8): this is
considered as a precocious sign of apoptosis (Fadok et
al., 1992). 
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Fig. 1.
Immunofluorescence
patterns of BrU
incorporation. As
compared to control
cells (a), in the cells
treated with 0.01
µg/ml AMD (b) the
nucleoli (arrows) were
devoid of
immunolabeling  (b’),
the same field as in b,
after staining of DNA
with Hoechst 33258:
note that nucleoli are
not stained). At higher
AMD concentrations (c, 0.1 and d, 1 µg/ml) also the extranucleolar labeling progressively decreased. Bar: 20 µm.
After treatments with higher AMD concentrations
(0.1 to 1 µg/ml), the percentage of apoptoptic cells
dramatically increased, as demonstrated by the dual-
parameter cytograms of annexin V-positivity versus PI
staining (Fig. 13); these evidence was also confirmed by
gel electrophoresis of low-molecular-weight DNA and
of PARP-1 degradation (personal observation, not
shown); interestingly enough, in these cells the
extranucleolar pre-mRNA synthesis still remained
active, although the incorporation of both BrU and 3H-
uridine progressively decreased (see Table 2). Even in
cells which, after treatment with higher AMD
concentrations, clearly exhibited morphological signs of
apoptosis (i.e. chromatin condensation, cytoplasmic
blebbing), BrU incorporation and DNA/RNA hybrid
molecules were still associated with the EDTA-positive
PF in the non-condensed chromatin regions (Fig. 9),
always in association with residual immunolabeling for
hnRNPs (Fig. 10). In these apoptotic cells, fibrogranular
RNP-containing structures were observed in the residual
areas of loosely dispesed chromatin: they contain
different splicing proteins, such as snRNPs and the SC-
35 splicing factor (Fig. 7c) and recall the heterogeneous
nuclear structures which have been called HERDS (for
Heterogeneous Ectopic RNP-derived Structures:
Biggiogera et al., 1998) which originate from the
segregation and the displacement of nucleolar and extra-
nucleolar RNPs from their original nuclear sites.
HERDS may move from the nucleus to the cytoplasm to
be extruded from the cell in the late apoptotic stages: in
fact, in our model system fluorescent aggregates
immunoreactive for the SC-35 splicing factor were
observed outside the nucleus of AMD-induced apoptotic
HeLa cells (Fig. 7c, inset). It is worth noting that, in our
experiments, hnRNP proteins were never observed to
aggregate into these ectopic RNP clusters: this is in
agreeement with the Western blot analyses (Fig. 11)
which demonstrated that in control cells two main bands
of 33 and 40 kDa were recognized by the antibody
against hnRNP core-proteins, whereas after treatment
with high concentrations of AMD the band with higher
molecular weight disappeared; this suggests that
hnRNPs are degraded in situ during apoptosis, whereas
it is known that other RNP-containing antigens (such as
the Sm antigen) are not degraded (Casiano et al., 1996;
Biggiogera et al., 2004). 
Discussion
Our data on HeLa cells confirm the reports in the
literature on AMD inhibition of r-RNA synthesis: this
was demonstrated both by absence of BrU incorporation
and by the lack of labeling for DNA/RNA hybrid
molecules in the nucleolus, a method used for the first
time under these conditions. These events were
paralleled by the segregation of nucleolar components,
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Fig. 2. Dual-parameter cytograms
of BrU incorporation (FITC-
immunolabeling, in ordinate),
versus PI-DNA content (in
abscissa). BrU incorporation
progressively decreased with
increasing AMD concentration.
The horizontal l ine in each
cytograms is for the FITC-
fluorescence values of negative
controls.
Table 2. Quantitative study.
CONTROL AMD 0.01 µg/ml AMD 0.1 µg/ml AMD 1 µg/ml
BrU incorporation (immunofluorescence intensity) 182.0±2.3 (100%) 123.0±3.0 (67.0%) 82.4±3.1 (45.3%) 38.9±4.3 (21.4%)
3H-Uridine incorporation (radioactivity) 1776±8.2 (100%) 899±10.9 (50.8%) 576±8.9 (32.6%) 144±1.4 (8.5%)
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Fig. 3.
Immunolabeling with
anti-BrdU antibodies
and EDTA regressive
staining. In control
cells (a), the gold
particles label the
sites of BrU
incorporation on the
dense fibrillar
component of the
nucleolus (Nu) and
on PF (arrows). After
0.01 AMD (b), the
segregated nucleolus
(Nu) appears devoid
of immunolabeling
whereas PF (arrows)
are still labeled. Bar:
0.5 µm.
Fig. 4. Strong
immunolabeling for
DNA/RNA hybrid
molecules was
observed all over the
nucleus (including the
nucleolus) in control
cells (a), whereas
after 0.01 AMD
treatment (b)
DNA/RNA hybrid
molecules are not
immunodetectable in
the segregated
nucleolus (Nu), while
they are still present
on PF (arrows). Bar:
0.5 µm.
 
which is a typical structural sign of functional
inactivation of the nucleolus (Puvion and Puvion-
Dutilleul, 1996; Fakan, 2004). 
On the contrary, the synthesis of pre-mRNAs still
remained active (although gradually decreasing) for
longer treatment times (up to 12 hr), as shown by the
occurrence of BrU incorporation and by the presence of
DNA/RNA hybrids on PF. However, the
immunopositivity for snRNPs and SC-35 strongly
decreased on PF, and the scanty residual labelling was
mostly confined to IG: this decrease is considered as a
hallmark of defective processing of the extranucleolar
transcripts. In fact, PF are made of nascent hnRNAs (or
pre-mRNAs), hnRNPs, snRNPs and the SC-35 splicing
factor (Fakan et al., 1986; Spector et al., 1991; Fakan,
1994, 2004; Cmarko et al., 1999) and have been
recognized as the morphological expression of
extranucleolar transcription and co-transcriptional
splicing. The residual splicing proteins in the nucleus,
located in the IG, should be non-functional. Actually, IG
represent storage sites of hypophosphorylated snRNPs
and serine-arginine rich proteins, such as SC-35 (Fakan,
1994, 2004; Misteli and Spector, 1998): only after being
activated by phosphorylation, they can be recruited from
IG to PF (Caceres et al., 1997; Misteli and Spector,
1997). On the other hand, IG can also contain released
transcripts which are believed to move from DNA the
reservoirs of splicing factors (Melcak et al., 2000).
The overall decrease in the immunolabeling for
these proteins after treatment with 0.01 µg/ml AMD
could be ascribed either to an inhibition of their
synthesis or to their storage inside IG which results in
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Fig. 5.
Immunonogold
labeling of hnRNP
core proteins. In
control cells (a), the
gold grains were
exclusively located
on PF (arrows),
where hnRNP core
proteins were still
detectable after
treatment with 0.01
mg/ml AMD (b). Bar:
0.5 µm.
Fig. 6. Immunogold
labeling for snRNP.
In control cell (a),
PF (arrows) and IG
were typically
labeled, whereas
after treatment with
0.01 mg/ml AMD, a
rather scarce
immunolabeling for
snRNPs can be
observed (Nu:
nucleolus); after
AMD treatment (b),
the labeling
decreases mainly on
PF (arrows), while
IG are still labeled;
in the micrograph, a
segregated
nucleolus (Nu) was
observed. Inset:
gold-labeling with
Annexin V of the
phosphatidylserine
residues on the
plasma membrane
of a cell with
segregated
nucleolus (not
shown). Bar: 
0.5 µm.
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Fig. 7.
Immunolabeling for
the SC-35 splicing
factor. In control cells,
PF and IG were
mainly labeled (a);
inset: FITC
immunofluorescence
of SC-35 is present
either as “spots”or in
a diffuse form. After
0.01 µg/ml AMD (b),
the labeling for SC-35
was mainly present
on IG, whereas PF
(arrow) were clearly
less labeled; inset:
the
immunofluoresence
appears only as
“spots”. Nu:
nucleolus. After 0.1
Fig. 8. Dual-parameter cytograms
of FITC-conjugated Annexin V (in
abscissa) versus propidium
iodide (PI, in ordinate). In control
cell cultures (CTR) almost all the
events fell in quadrant 1, being
negative for both Annexin V and
PI; the few cells in quadrant 4 are
spontaneously apoptotic cells,
positive for both dyes. After 0.01
µg/ml of AMD, early apoptotic
cells, which are posit ive for
Annexin V (quadrant 2) but
negative for PI (being their
membrane still able to exclude
PI) can be found, whereas at
higher concentrations (0.1 and 1
µg/ml of AMD) a large number of
late apoptotic cells (positive for
both Annexin V and PI: quadrant
4) were present.
µg/ml AMD treatment (c), the SC-35 splicing factor can be detected in ectopic aggregates (arrowheads) which move from the nucleus to the cytoplasm
in late apoptotic cells (inset). Bar: 0.5 µm.
 
the clustering and, probably, masking of the epitope. In
fact, degradation of these proteins is unlikely, since they
are not among the known targets of caspases (Casiano et
al., 1996; Fischer et al., 2003). Actually, these
precocious alterations are likely to precede the activation
of effective caspases (Scovassi and Torriglia, 2003),
since chromatin did not undergo significant structural
changes and no DNA laddering, nor PARP-1
degradation were observed to occur (personal
unpublished observation); nevertheless, the plasma
membrane of treated cells showed typical early apoptotic
features, such as the exposure of phosphatidylserine on
the extracellular surface (Fadok et al., 1992; Martin et
al., 1995).
At higher AMD concentrations (between 0.1 and 1
µg/ml), apoptosis massively occured with the typical
morphological, cytochemical and cytometric evidence.
Interestingly enough, residual extranucleolar RNA
synthesis (demonstrated by BrU incorporation and the
presence of DNA/RNA hybrid molecules) was still
active in non-condensed chromatin, while apoptosis
proceeds. Pre-mRNA maturation was, however,
impaired since snRNP and the SC-35 splicing factor
segregated from their usual nuclear locations, and
entered the HERDS clusters, which passed into the
cytoplasm prior to be released at the cell surface, inside
apoptotic bodies. These structures have also been
observed in different cell types where transcription was
arrested, either physiologically or experimentally
(Biggiogera et al., 1998, 2004; Biggiogera and
Pellicciari, 2000). In our experiments, hnRNPs followed
a different fate, and never participated in the formation
of ectopic RNP aggregates. 
We may conclude that the inhibition of r-RNA
synthesis (with the consequent block in ribosome
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Fig. 9. BrU
immunolabeling and
regressive EDTA
staining of HeLa cells
after 0.1 µg/ml AMD
treatment. Chromatin
(Ch, bleached by this
procedure) is
extensively
condensed. Few
stained RNP
structures still
incorporate BrU
(arrows). Bar: 0,5 µm.
Fig. 10. Immunogold
labeling of hnRNP
core proteins and
regressive EDTA
staining in a cell
treated with 0.1 µg/ml
of AMD. The hnRNPs
are still present in
EDTA-stained
structures (arrows)
inside the bleached
chromatin (Ch).
Arrowheads point to ectopic aggregates, which are devoided of hnRNP. Bar: 0.5 µm.
Fig. 11. Western blot of hnRNPs. In control cells (CTR), as well as in
cells treated with 0.01 and 0.1 µg/ml of AMD, two bands are present.
After treatment with 1 µg/ml of AMD, only one protein band is
detectable, suggesting a partial degradation of the hnRNPs. 
production) and the defective pre-mRNA maturation
seem to represent an early step of the AMD-induced
apoptotic process: it may be hypothesized that these
events may affect the equilibrium between transcription
(still persisting until late apoptotic stages in the
extranucleolar areas) and translation of some regulatory
proteins required to maintain the control of the overall
apoptotic machinery (Martin et al., 1990; Andera and
Wasylyk, 1997; Peter et al., 1999).
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